Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 147

1.

Susceptibility loci for murine HIV-associated nephropathy encode trans-regulators of podocyte gene expression.

Papeta N, Chan KT, Prakash S, Martino J, Kiryluk K, Ballard D, Bruggeman LA, Frankel R, Zheng Z, Klotman PE, Zhao H, D'Agati VD, Lifton RP, Gharavi AG.

J Clin Invest. 2009 May;119(5):1178-88. doi: 10.1172/JCI37131. Epub 2009 Apr 20.

2.

Genetic susceptibility to HIV-associated nephropathy.

Quaggin SE.

J Clin Invest. 2009 May;119(5):1085-9.

3.

Background strain and the differential susceptibility of podocyte-specific deletion of Myh9 on murine models of experimental glomerulosclerosis and HIV nephropathy.

Johnstone DB, Ikizler O, Zhang J, Holzman LB.

PLoS One. 2013 Jul 10;8(7):e67839. doi: 10.1371/journal.pone.0067839. Print 2013.

4.

Identification of the nephropathy-susceptibility locus HIVAN4.

Prakash S, Papeta N, Sterken R, Zheng Z, Thomas RL, Wu Z, Sedor JR, D'Agati VD, Bruggeman LA, Gharavi AG.

J Am Soc Nephrol. 2011 Aug;22(8):1497-504. doi: 10.1681/ASN.2011020209. Epub 2011 Jul 22.

5.

Expression of HIV-1 genes in podocytes alone can lead to the full spectrum of HIV-1-associated nephropathy.

Zhong J, Zuo Y, Ma J, Fogo AB, Jolicoeur P, Ichikawa I, Matsusaka T.

Kidney Int. 2005 Sep;68(3):1048-60.

6.

The molecular pathogenesis of HIV-1 associated nephropathy: recent advances.

Papeta N, Sterken R, Kiryluk K, Kalyesubula R, Gharavi AG.

J Mol Med (Berl). 2011 May;89(5):429-36. doi: 10.1007/s00109-010-0719-x. Epub 2011 Jan 11. Review.

PMID:
21221512
7.

HIV-associated nephropathy: experimental models.

Avila-Casado C, Fortoul TI, Chugh SS.

Contrib Nephrol. 2011;169:270-85. doi: 10.1159/000320212. Epub 2011 Jan 20.

PMID:
21252526
8.

Refinement of the HIVAN1 Susceptibility Locus on Chr. 3A1-A3 via Generation of Sub-Congenic Strains.

Papeta N, Patel A, D'Agati VD, Gharavi AG.

PLoS One. 2016 Oct 13;11(10):e0163860. doi: 10.1371/journal.pone.0163860. eCollection 2016.

9.

Deletion of podocyte STAT3 mitigates the entire spectrum of HIV-1-associated nephropathy.

Gu L, Dai Y, Xu J, Mallipattu S, Kaufman L, Klotman PE, He JC, Chuang PY.

AIDS. 2013 Apr 24;27(7):1091-8. doi: 10.1097/QAD.0b013e32835f1ea1.

10.

APOL1 variants increase risk for FSGS and HIVAN but not IgA nephropathy.

Papeta N, Kiryluk K, Patel A, Sterken R, Kacak N, Snyder HJ, Imus PH, Mhatre AN, Lawani AK, Julian BA, Wyatt RJ, Novak J, Wyatt CM, Ross MJ, Winston JA, Klotman ME, Cohen DJ, Appel GB, D'Agati VD, Klotman PE, Gharavi AG.

J Am Soc Nephrol. 2011 Nov;22(11):1991-6. doi: 10.1681/ASN.2011040434. Epub 2011 Oct 13.

11.

HIV-1 genes vpr and nef synergistically damage podocytes, leading to glomerulosclerosis.

Zuo Y, Matsusaka T, Zhong J, Ma J, Ma LJ, Hanna Z, Jolicoeur P, Fogo AB, Ichikawa I.

J Am Soc Nephrol. 2006 Oct;17(10):2832-43. Epub 2006 Sep 20.

12.

NF-kappaB regulates Fas-mediated apoptosis in HIV-associated nephropathy.

Ross MJ, Martinka S, D'Agati VD, Bruggeman LA.

J Am Soc Nephrol. 2005 Aug;16(8):2403-11. Epub 2005 Jun 23.

13.

Mapping a locus for susceptibility to HIV-1-associated nephropathy to mouse chromosome 3.

Gharavi AG, Ahmad T, Wong RD, Hooshyar R, Vaughn J, Oller S, Frankel RZ, Bruggeman LA, D'Agati VD, Klotman PE, Lifton RP.

Proc Natl Acad Sci U S A. 2004 Feb 24;101(8):2488-93.

14.

Angiotensin II provokes podocyte injury in murine model of HIV-associated nephropathy.

Ideura H, Hiromura K, Hiramatsu N, Shigehara T, Takeuchi S, Tomioka M, Sakairi T, Yamashita S, Maeshima A, Kaneko Y, Kuroiwa T, Kopp JB, Nojima Y.

Am J Physiol Renal Physiol. 2007 Oct;293(4):F1214-21. Epub 2007 Jul 25.

PMID:
17652372
15.

Role of the retinoic acid receptor-α in HIV-associated nephropathy.

Ratnam KK, Feng X, Chuang PY, Verma V, Lu TC, Wang J, Jin Y, Farias EF, Napoli JL, Chen N, Kaufman L, Takano T, D'Agati VD, Klotman PE, He JC.

Kidney Int. 2011 Mar;79(6):624-34. doi: 10.1038/ki.2010.470. Epub 2010 Dec 8.

16.

HIV-associated nephropathy: pathogenesis.

Medapalli RK, He JC, Klotman PE.

Curr Opin Nephrol Hypertens. 2011 May;20(3):306-11. doi: 10.1097/MNH.0b013e328345359a. Review.

17.

Angiotensin II type 1 receptor blockade inhibits the development and progression of HIV-associated nephropathy in a mouse model.

Hiramatsu N, Hiromura K, Shigehara T, Kuroiwa T, Ideura H, Sakurai N, Takeuchi S, Tomioka M, Ikeuchi H, Kaneko Y, Ueki K, Kopp JB, Nojima Y.

J Am Soc Nephrol. 2007 Feb;18(2):515-27. Epub 2007 Jan 17.

18.

Close relations between podocyte injuries and membranous proliferative glomerulonephritis in autoimmune murine models.

Kimura J, Ichii O, Otsuka S, Sasaki H, Hashimoto Y, Kon Y.

Am J Nephrol. 2013;38(1):27-38. doi: 10.1159/000353093. Epub 2013 Jun 26.

PMID:
23817053
19.

Accelerated development of collapsing glomerulopathy in mice congenic for the HIVAN1 locus.

Chan KT, Papeta N, Martino J, Zheng Z, Frankel RZ, Klotman PE, D'Agati VD, Lifton RP, Gharavi AG.

Kidney Int. 2009 Feb;75(4):366-72. doi: 10.1038/ki.2008.625. Epub 2008 Dec 17.

20.

Kruppel-like factor 15 (KLF15) is a key regulator of podocyte differentiation.

Mallipattu SK, Liu R, Zheng F, Narla G, Ma'ayan A, Dikman S, Jain MK, Saleem M, D'Agati V, Klotman P, Chuang PY, He JC.

J Biol Chem. 2012 Jun 1;287(23):19122-35. doi: 10.1074/jbc.M112.345983. Epub 2012 Apr 9.

Supplemental Content

Support Center